Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

Press releases published on October 27, 2026

Oct. 27, 2026

aTyr Pharma Announces One-for-40 Reverse Stock Split

Indeterminate GlobeNewswire

Oct. 27, 2026

The Gene Lay Institute of Immunology and Inflammation Expands World-Class Research Leadership, Appointing Four New Members

Indeterminate GlobeNewswire

Oct. 27, 2026

Exagen to Announce Third Quarter Financial Results on November 10, 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

New Crisis Text Line Report, Funded by Nike, Finds Youth in Crisis Rely on Sports and Movement to Cope

Indeterminate GlobeNewswire

Oct. 27, 2026

Syncromune Reports Long-Term Data from Phase 1 Study in Metastatic Prostate Cancer with Investigational SYNC-T Therapy SV-102

Indeterminate GlobeNewswire

Oct. 27, 2026

Emerging Digital Health Companies Choose HealthEx’s Platform and Health Records API to Personalize User Experiences with Clinical Context

Indeterminate GlobeNewswire

Oct. 27, 2026

Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments

Indeterminate GlobeNewswire

Oct. 27, 2026

Nexalin Technology Announces Fourth Peer-Reviewed Publication in Alzheimer's Disease: 15 mA DIFS™ Significantly Improves Sleep Quality in Patients with Mild Alzheimer's Disease

Indeterminate GlobeNewswire

Oct. 27, 2026

Bonafide® Health Introduces Women’s Daily Creatine & Collagen Supplement

Indeterminate GlobeNewswire

Oct. 27, 2026

Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Indeterminate GlobeNewswire

Oct. 27, 2026

NEXGEL Regains Compliance with Nasdaq Listing Requirement

Indeterminate GlobeNewswire

Oct. 27, 2026

Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System

Indeterminate GlobeNewswire

Oct. 27, 2026

Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement

Indeterminate GlobeNewswire

Oct. 27, 2026

Clearmind Successfully Completes Patient Recruitment for the First Alcohol Use Disorder Cohort of its CMND-100 Phase I/IIa Clinical Trial

Indeterminate GlobeNewswire

Oct. 27, 2026

Polyrizon Announces Successful Completion Enrollment of all 120 Patients in U.S. Clinical Study of NASARIX Allergy Blocker

Indeterminate GlobeNewswire

Oct. 27, 2026

60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients

Indeterminate GlobeNewswire

Oct. 27, 2026

BillionToOne to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire

Oct. 27, 2026

Candel Therapeutics to Present at November Investor Conferences

Indeterminate GlobeNewswire

Oct. 27, 2026

Human Appeal’s Winter Comedy Tour returns for the 12th year running in aid of orphaned children

Indeterminate GlobeNewswire

Oct. 27, 2026

Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026

Indeterminate GlobeNewswire